FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014365116> ?p ?o ?g. }

• W2014365116 endingPage "791" @default.
• W2014365116 startingPage "786" @default.
• W2014365116 abstract "Landmark studies have proved that several therapies reduce cardiovascular disease (CVD) risk; however, the rates of secondary CVD in the context of therapies delivered according to current guidelines are largely unknown. Therefore, we sought to estimate the incidence of secondary CVD hospitalizations and all-cause mortality among patients who did and did not receive guideline-level pharmacotherapy. For the 12,278 patients added to the Kaiser Permanente, Northwest CVD registry in 2000 to 2005, we used the pharmacy records to define guideline-level care (GLC) as at least one dispense of aspirin/antiplatelets, statins, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and β blockers within 6 months after registry enrollment. We followed patients until they died, experienced a CVD hospitalization, or June 30, 2008. We compared the age- and gender-adjusted incidence rates per 1,000 person-years of CVD hospitalization, death, and the composite, and estimated the hazard ratios using Cox regression analysis. During a mean follow-up of 45.8 ± 22.8 months, 25% of the study sample experienced the composite outcome. The age- and gender-adjusted incidence per 1,000 person-years of the composite outcome was significantly lower among GLC patients (hazard ratio 50.3, 95% confidence interval [CI] 46.6 to 54.3) versus non-GLC patients (hazard ratio 60.7, 95% CI 58.1 to 63.4). The difference was driven by lower mortality rates (hazard ratio 18.1, 95% CI 16.1 to 20.4 vs hazard ratio 28.1, 95% CI 26.3 to 30.0). The incidence of CVD hospitalizations did not differ significantly between the 2 groups (hazard ratio 29.2, 95% CI 26.4 to 32.2 vs hazard ratio 27.7, 95% CI 26.0 to 29.5). Multivariate adjustment resulted in a marginally significant 8% lower risk of the composite outcome among GLC recipients (hazard ratio 0.92, 95% CI 0.83 to 1.01, p = 0.067). In conclusion, treatment according to current guidelines was significantly associated with reduced mortality but not the risk of secondary hospitalizations. Landmark studies have proved that several therapies reduce cardiovascular disease (CVD) risk; however, the rates of secondary CVD in the context of therapies delivered according to current guidelines are largely unknown. Therefore, we sought to estimate the incidence of secondary CVD hospitalizations and all-cause mortality among patients who did and did not receive guideline-level pharmacotherapy. For the 12,278 patients added to the Kaiser Permanente, Northwest CVD registry in 2000 to 2005, we used the pharmacy records to define guideline-level care (GLC) as at least one dispense of aspirin/antiplatelets, statins, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and β blockers within 6 months after registry enrollment. We followed patients until they died, experienced a CVD hospitalization, or June 30, 2008. We compared the age- and gender-adjusted incidence rates per 1,000 person-years of CVD hospitalization, death, and the composite, and estimated the hazard ratios using Cox regression analysis. During a mean follow-up of 45.8 ± 22.8 months, 25% of the study sample experienced the composite outcome. The age- and gender-adjusted incidence per 1,000 person-years of the composite outcome was significantly lower among GLC patients (hazard ratio 50.3, 95% confidence interval [CI] 46.6 to 54.3) versus non-GLC patients (hazard ratio 60.7, 95% CI 58.1 to 63.4). The difference was driven by lower mortality rates (hazard ratio 18.1, 95% CI 16.1 to 20.4 vs hazard ratio 28.1, 95% CI 26.3 to 30.0). The incidence of CVD hospitalizations did not differ significantly between the 2 groups (hazard ratio 29.2, 95% CI 26.4 to 32.2 vs hazard ratio 27.7, 95% CI 26.0 to 29.5). Multivariate adjustment resulted in a marginally significant 8% lower risk of the composite outcome among GLC recipients (hazard ratio 0.92, 95% CI 0.83 to 1.01, p = 0.067). In conclusion, treatment according to current guidelines was significantly associated with reduced mortality but not the risk of secondary hospitalizations." @default.
• W2014365116 created "2016-06-24" @default.
• W2014365116 creator A5002661071 @default.
• W2014365116 creator A5027170050 @default.
• W2014365116 creator A5080248267 @default.
• W2014365116 date "2010-03-01" @default.
• W2014365116 modified "2023-09-28" @default.
• W2014365116 title "Comparison of Evidence-Based Versus Non–Evidence-Based Pharmacotherapy on the Risk of Cardiovascular Hospitalization and All-Cause Mortality Among Patients With Established Cardiovascular Disease" @default.
• W2014365116 cites W113869680 @default.
• W2014365116 cites W1963719682 @default.
• W2014365116 cites W1982036768 @default.
• W2014365116 cites W1991018702 @default.
• W2014365116 cites W2011847848 @default.
• W2014365116 cites W2019171072 @default.
• W2014365116 cites W2026759872 @default.
• W2014365116 cites W2029412045 @default.
• W2014365116 cites W2040087929 @default.
• W2014365116 cites W2040816046 @default.
• W2014365116 cites W2040885081 @default.
• W2014365116 cites W2057112394 @default.
• W2014365116 cites W2086077933 @default.
• W2014365116 cites W2106244081 @default.
• W2014365116 cites W2106757324 @default.
• W2014365116 cites W2133677561 @default.
• W2014365116 cites W2142532695 @default.
• W2014365116 cites W2162067185 @default.
• W2014365116 cites W2167067204 @default.
• W2014365116 cites W2247997571 @default.
• W2014365116 cites W2549031161 @default.
• W2014365116 doi "https://doi.org/10.1016/j.amjcard.2009.11.008" @default.
• W2014365116 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20211320" @default.
• W2014365116 hasPublicationYear "2010" @default.
• W2014365116 type Work @default.
• W2014365116 sameAs 2014365116 @default.
• W2014365116 citedByCount "6" @default.
• W2014365116 countsByYear W20143651162013 @default.
• W2014365116 countsByYear W20143651162016 @default.
• W2014365116 countsByYear W20143651162017 @default.
• W2014365116 countsByYear W20143651162018 @default.
• W2014365116 crossrefType "journal-article" @default.
• W2014365116 hasAuthorship W2014365116A5002661071 @default.
• W2014365116 hasAuthorship W2014365116A5027170050 @default.
• W2014365116 hasAuthorship W2014365116A5080248267 @default.
• W2014365116 hasConcept C120665830 @default.
• W2014365116 hasConcept C121332964 @default.
• W2014365116 hasConcept C126322002 @default.
• W2014365116 hasConcept C142724271 @default.
• W2014365116 hasConcept C151730666 @default.
• W2014365116 hasConcept C167704817 @default.
• W2014365116 hasConcept C207103383 @default.
• W2014365116 hasConcept C2777628954 @default.
• W2014365116 hasConcept C2779343474 @default.
• W2014365116 hasConcept C2780182762 @default.
• W2014365116 hasConcept C44249647 @default.
• W2014365116 hasConcept C500440147 @default.
• W2014365116 hasConcept C50382708 @default.
• W2014365116 hasConcept C61511704 @default.
• W2014365116 hasConcept C71924100 @default.
• W2014365116 hasConcept C86803240 @default.
• W2014365116 hasConceptScore W2014365116C120665830 @default.
• W2014365116 hasConceptScore W2014365116C121332964 @default.
• W2014365116 hasConceptScore W2014365116C126322002 @default.
• W2014365116 hasConceptScore W2014365116C142724271 @default.
• W2014365116 hasConceptScore W2014365116C151730666 @default.
• W2014365116 hasConceptScore W2014365116C167704817 @default.
• W2014365116 hasConceptScore W2014365116C207103383 @default.
• W2014365116 hasConceptScore W2014365116C2777628954 @default.
• W2014365116 hasConceptScore W2014365116C2779343474 @default.
• W2014365116 hasConceptScore W2014365116C2780182762 @default.
• W2014365116 hasConceptScore W2014365116C44249647 @default.
• W2014365116 hasConceptScore W2014365116C500440147 @default.
• W2014365116 hasConceptScore W2014365116C50382708 @default.
• W2014365116 hasConceptScore W2014365116C61511704 @default.
• W2014365116 hasConceptScore W2014365116C71924100 @default.
• W2014365116 hasConceptScore W2014365116C86803240 @default.
• W2014365116 hasFunder F4320307773 @default.
• W2014365116 hasIssue "6" @default.
• W2014365116 hasLocation W20143651161 @default.
• W2014365116 hasLocation W20143651162 @default.
• W2014365116 hasOpenAccess W2014365116 @default.
• W2014365116 hasPrimaryLocation W20143651161 @default.
• W2014365116 hasRelatedWork W1727188710 @default.
• W2014365116 hasRelatedWork W2088206352 @default.
• W2014365116 hasRelatedWork W2119154902 @default.
• W2014365116 hasRelatedWork W2133235702 @default.
• W2014365116 hasRelatedWork W2135028155 @default.
• W2014365116 hasRelatedWork W2203903734 @default.
• W2014365116 hasRelatedWork W2904476754 @default.
• W2014365116 hasRelatedWork W2917746345 @default.
• W2014365116 hasRelatedWork W4235326945 @default.
• W2014365116 hasRelatedWork W4376871959 @default.
• W2014365116 hasVolume "105" @default.
• W2014365116 isParatext "false" @default.
• W2014365116 isRetracted "false" @default.
• W2014365116 magId "2014365116" @default.
• W2014365116 workType "article" @default.